Molina Healthcare’s strong performance contributed to Sycamore Mid Cap Value’s 9.6% Q2 return amid broader market shifts.
Molina Healthcare (MOH) bolstered Sycamore Capital Management’s Mid Cap Value Equity Strategy in Q2 2026, as the fund posted a 9.6% net return. The gain trailed the Russell Midcap Value Index’s 13.83% return due to stock selection and sector allocation challenges.
Small-cap equities outperformed mid- and large-cap peers during the quarter, while the S&P 500 saw significant gains driven by AI-related momentum. Market concentration and passive investment risks were flagged as concerns for investors.
The strategy’s focus on undervalued businesses with growth potential included Molina Healthcare, which operates in Medicaid, Medicare, and Marketplace segments. The stock’s performance on August 12, 2026, was noted as a key contributor.